S B Ebeling

520 total citations
17 papers, 272 citations indexed

About

S B Ebeling is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, S B Ebeling has authored 17 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 5 papers in Hematology. Recurrent topics in S B Ebeling's work include T-cell and B-cell Immunology (8 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (6 papers). S B Ebeling is often cited by papers focused on T-cell and B-cell Immunology (8 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (6 papers). S B Ebeling collaborates with scholars based in Netherlands, Germany and United Kingdom. S B Ebeling's co-authors include Anton Hagenbeek, Rick Kapur, Mark Schütte, Ton Logtenberg, Tom van Meerten, Samantha Hol, L Aarden, Marc Ehlers, Stefan Rose‐John and Roman Ivanov and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

S B Ebeling

16 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S B Ebeling Netherlands 10 160 102 66 64 62 17 272
Aldo Gasparollo Italy 7 236 1.5× 90 0.9× 133 2.0× 47 0.7× 48 0.8× 9 343
Hui Qin China 7 171 1.1× 169 1.7× 125 1.9× 53 0.8× 71 1.1× 14 325
Ameera Alsadeq Germany 7 114 0.7× 68 0.7× 62 0.9× 27 0.4× 63 1.0× 16 264
I K McNiece United States 6 157 1.0× 81 0.8× 86 1.3× 53 0.8× 149 2.4× 6 350
Jenni E. Crowley United States 8 292 1.8× 34 0.3× 44 0.7× 58 0.9× 23 0.4× 8 365
Yu Abe Japan 9 186 1.2× 169 1.7× 102 1.5× 33 0.5× 99 1.6× 27 326
Jessica Herrath Sweden 8 214 1.3× 32 0.3× 46 0.7× 46 0.7× 29 0.5× 8 326
Anne‐Lise Maudoux Belgium 3 119 0.7× 49 0.5× 28 0.4× 44 0.7× 23 0.4× 3 247
Sanki Kodera Japan 7 235 1.5× 26 0.3× 52 0.8× 63 1.0× 18 0.3× 10 307
Jeff Kilpatrick United States 8 238 1.5× 38 0.4× 45 0.7× 77 1.2× 26 0.4× 9 364

Countries citing papers authored by S B Ebeling

Since Specialization
Citations

This map shows the geographic impact of S B Ebeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S B Ebeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S B Ebeling more than expected).

Fields of papers citing papers by S B Ebeling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S B Ebeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S B Ebeling. The network helps show where S B Ebeling may publish in the future.

Co-authorship network of co-authors of S B Ebeling

This figure shows the co-authorship network connecting the top 25 collaborators of S B Ebeling. A scholar is included among the top collaborators of S B Ebeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S B Ebeling. S B Ebeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Ebeling, S B, et al.. (2023). Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells. Frontiers in Oncology. 13. 1171794–1171794. 21 indexed citations
3.
Resemann, Henrike K., Liane te Boome, Debbie van Baarle, et al.. (2011). The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study. Haematologica. 96(9). 1380–1384. 11 indexed citations
4.
Dorp, Suzanne van, Henrike K. Resemann, Eefke Petersen, et al.. (2011). Rituximab Treatment in Chronic GVHD: Clinical Efficacy Associates With Restoring a Physiological B-Cell Balance. Biology of Blood and Marrow Transplantation. 17(2). S329–S329. 1 indexed citations
5.
6.
Kapur, Rick, S B Ebeling, & Anton Hagenbeek. (2008). B-cell involvement in chronic graft-versus-host disease. Haematologica. 93(11). 1702–1711. 40 indexed citations
7.
8.
9.
Robinet, Éric, Boris Fehse, S B Ebeling, et al.. (2005). Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function. Cytotherapy. 7(2). 150–157. 15 indexed citations
10.
11.
Ivanov, Roman, et al.. (2005). T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens. Clinical & Experimental Immunology. 143(1). 78–84. 5 indexed citations
12.
Ebeling, S B, Elles Simonetti, H P E Borst, et al.. (2003). Human primary T lymphocytes have a low capacity to amplify MLV-based amphotropic RCR and the virions produced are largely noninfectious. Gene Therapy. 10(21). 1800–1806. 3 indexed citations
13.
Ebeling, S B, Robert J. Slater, Wilhelmina J. I. Overkamp, et al.. (1998). Human chromosome 21 determines growth factor dependence in human/mouse B-cell hybridomas.. PubMed. 58(13). 2863–8. 4 indexed citations
14.
Hon, Floris D. de, Marc Ehlers, Stefan Rose‐John, et al.. (1994). Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.. The Journal of Experimental Medicine. 180(6). 2395–2400. 45 indexed citations
15.
Ebeling, S B, Mark Schütte, & Ton Logtenberg. (1993). Peripheral human CD5+ and CD5- B cells may express somatically mutated VH5- and VH6-encoded IgM receptors.. The Journal of Immunology. 151(12). 6891–6899. 30 indexed citations
16.
17.
Small, Gary W., S B Ebeling, Steven S. Matsuyama, et al.. (1991). Variable association of HLA-A2 in men with early-onset Alzheimer disease☆. Neurobiology of Aging. 12(4). 375–377. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aldo Gasparollo Breakdown of academic impact, for papers by Hui Qin Breakdown of academic impact, for papers by Ameera Alsadeq Breakdown of academic impact, for papers by I K McNiece Breakdown of academic impact, for papers by Jenni E. Crowley Breakdown of academic impact, for papers by Yu Abe Breakdown of academic impact, for papers by Jessica Herrath Breakdown of academic impact, for papers by Anne‐Lise Maudoux Breakdown of academic impact, for papers by Sanki Kodera Breakdown of academic impact, for papers by Jeff Kilpatrick
Rankless by CCL
2026